SQUAWK/NEWS
Account
Theme
Account
Menu
Live News MNA FLASH M impact

Calytrix Bio Agrees to Be Acquired by Lilly

Calytrix Bio said it entered an agreement to be acquired by Lilly. Its preclinical program targets essential thrombocythemia and myelofibrosis.

Related stories